Tag: AMA CPT codes

AMA Releases The CPT 2024 Code Set


AMA Adopts Policy Supporting Importation of Prescription Drugs from ...To bridge language barriers and make healthcare more inclusive and transparent for patients who speak Spanish, the American Medical Association (AMA) now offers Spanish language descriptors for more than 11,000 medical procedures and services.

The consumer-friendly descriptors in Spanish were added to the newly released Current Procedural Terminology (CPT) 2024 code set, the nation’s leading data-sharing terminology for medical procedures and services.

The consumer-friendly descriptors are an important resource that many hospitals, health plans, medical offices and other CPT users already incorporate into English-language medical documents, insurance forms, price sheets, and patient portals. Including CPT consumer-friendly descriptors in Spanish that are clear and straightforward will help CPT users better engage and assist many in the Latinx community.

“Navigating medical care and paperwork can be especially challenging for Latinx patients who do not speak English or speak English as a second language,” said AMA senior vice president of health solutions Lori Prestesater. “Providing approximately 41 million Spanish speaking individuals in the United States with an easy-to-understand description of medical procedures and services can help build a more inclusive health care environment, where language is no longer a barrier and patients can actively engage in their own care.”

Other changes to the CPT code set

The annual update to the CPT code set created 349 editorial changes, including 230 additions, 49 deletions and 70 revisions. With 11,163 codes that describe the medical procedures and services available to patients, the CPT code set continues to grow and evolve with the rapid pace of innovation in medical science and health technology.

Changes to the CPT code set are considered through an open editorial process managed by the CPT Editorial Panel, an independent body convened by the AMA that collects broad input from the health care community and beyond to ensure CPT content reflects the coding and data-driven demands of a modern health care system. This rigorous editorial process keeps the CPT code set current with contemporary medical science and technology so it can fulfill its vital role as the trusted language of medicine today and the code to its future.

Continue Reading

AMA Updates COVID-19 Vaccine CPT Codes

The American Medical Association (AMA) today announced that the Current Procedural Terminology (CPT) code set has been updated by the CPT Editorial Panel to include vaccine and administration codes that are unique to a new formulation of the COVID-19 vaccine developed by Pfizer. The new formulation is based on a tris-sucrose buffer rather than the phosphate buffer present in the original formulation.

The provisional CPT codes will be effective for use on the condition that tris-sucrose formulation of Pfizer’s COVID-19 vaccine receives approval or emergency use authorization from the U.S. Food and Drug Administration (FDA). The AMA is publishing the CPT code update now to ensure electronic systems across the U.S. health care system are prepared in advance for the potential FDA approval or authorization of the tris-sucrose formulation of Pfizer’s COVID-19 vaccine.

The development of vaccine-specific CPT codes has clinically distinguished each coronavirus vaccine and dosing schedule for better tracking, reporting and analysis that supports data-driven planning and allocation. COVID-19 vaccines from AstraZeneca, Janssen (Johnson & Johnson), Moderna, Novavax and Pfizer’s original formulation have previously been issued unique CPT codes.

To help ensure accurate coding and reporting of COVID-19 vaccines and immunization services, the AMA offers a vaccine code finder resource to help identify the appropriate CPT code combination for the type and dose of COVID-19 vaccine provided to each patient.

For quick reference, the new vaccine and administration codes assigned to the tris-sucrose formulation of Pfizer’s COVID-19 vaccine are:

Continue Reading